EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl+ AML Therapy

Chunmou Li iD, Yuchen Wen, Jiasheng Wang, Lindi Li, Yue He, Yucai Cheng, Junru Chen, Junbin Huang, Cheng Ouyang, Yong Liu, Ruizhi Zhou iD, Haisheng Chen und 5 weitere

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s511713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Chunmou Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Leukemia, Myeloid, Acute, Exosomes, Daunorubicin. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsLeukemia, Myeloid, AcuteExosomesDaunorubicinHumansAnimalsMiceProto-Oncogene MasCell Line, TumorDrug Delivery SystemsAntineoplastic AgentsRecombinant Fusion Proteins

Stichwörter der Autor:innen

AMLc-Mplengineeringexosometargeted therapy

Substanzen

DaunorubicinMAS1 protein, humanProto-Oncogene MasAntineoplastic AgentsRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, 518107, People's Republic of China.
  • State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong, 510275, People's Republic of China.
  • Department of Pediatrics, Edmond H. Fischer Translational Medical Research Laboratory, Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518107, People's Republic…

ORCID-Profile: Chunmou Li, Ruizhi Zhou, Qing Zhang

Zitieren

APA

Li, C., Wen, Y., Wang, J., Li, L., He, Y., Cheng, Y., Chen, J., Huang, J., Ouyang, C., Liu, Y., Zhou, R., Chen, H., Li, F., Guo, Q., Chen, Y., Chen, C., & Zhang, Q. (2025). Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl+ AML Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s511713

Vancouver

Li C, Wen Y, Wang J, Li L, He Y, Cheng Y, et al. Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl+ AML Therapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s511713

BibTeX
@article{Li2025,
  author = {Li, Chunmou and Wen, Yuchen and Wang, Jiasheng and Li, Lindi and He, Yue and Cheng, Yucai and Chen, Junru and Huang, Junbin and Ouyang, Cheng and Liu, Yong and Zhou, Ruizhi and Chen, Haisheng and Li, Fei and Guo, Qiqi and Chen, Yun and Chen, Chun and Zhang, Qing},
  title = {Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl+ AML Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s511713}
}
Kostenlos starten →